In LOCUS MEDICUS we understand the importance of early diagnosis of various viral and bacterial infections for hospitalized patients in critical condition. As a result we would like to inform you that laboratory of molecular pathology and genetics will be accepting samples for molecular analysis 7 days a week (even during the holidays) upon request after contacting the on-call biologist on +30 6947949707. The test result will be available within a few hours. 

Cystic Fibrosis (CF) is the second most common genetic disease in Greece second only to Thalassemia (an estimated 5% of the Greek population is a carrier of a mutation or polymorphism associated with CF). Furthermore, in contrast to Thalassemia, a CF carrier does not exhibit some kind of clinical find so carrier screening is more difficult.

LOCUS-MEDICUS S.A. an active participant of the ΕΗΕQA European HPV DNA Test External Quality Assurance Scheme HPV uses a State-Of-The-Art system for genetic identification of HPV. Based on a low density microarray in conjunction with polymerase chain reaction (PCR) techniques, this system allows detection of  infections and coinfections of up to 35 of the most relevant HPV genotypes while at the same time this method exhibits  higher sensitivity and specificity compared to conventional PCR.